MedPath

Evaluation of the Effect of Melatonin and Valerian in Treatment of Tinitus

Not Applicable
Conditions
Tinitus.
Tinitus
Registration Number
IRCT2016011825083N3
Lead Sponsor
Deputy of Research and Technology of Hamedan University Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
78
Inclusion Criteria

Unilateral or Bilateral Tinitus in 18-65 years old patients

Exclusion criteria:Acute or chronic otitis media; Unilateral sensory neural hearing loss with abnormal MRI; Conductive hearing loss; Treatment with anticonvulsant and sedative drugs; Addiction; objective tinitus; Heart disease; Mixed hearing loss

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tinitus. Timepoint: One month after treatment. Method of measurement: Tinitus handicap inventory questionare.
Secondary Outcome Measures
NameTimeMethod
Improvement of sleep. Timepoint: One month after treatment. Method of measurement: Pittsburgh sleep questionare.
© Copyright 2025. All Rights Reserved by MedPath